Insider: Kulkarni Samarth Chief Executive Officer - CRISPR Therapeutics AG
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 255,501 | 0 | 255,501 |
| Value | $12,649,854.51 | $0.00 | $12,649,854.51 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/23/2026 | DDS | 10,020 | Direct | COM | $46.78 | $468,735.60 | 255,501 |
| 03/16/2026 | DDS | 10,349 | Direct | COM | $48.26 | $499,442.74 | 245,834 |
| 03/11/2026 | DDS | 9,798 | Direct | COM | $52.80 | $517,334.40 | 235,558 |
| 02/19/2026 | DDS | 6,967 | Direct | COM | $52.58 | $366,324.86 | 226,106 |
| 01/22/2026 | DDS | 60,000 | Direct | COM | $60.23 | $3,613,800.00 | 134,201 |
| 01/20/2026 | DDS | 21,433 | Direct | COM | $51.61 | $1,106,157.13 | 202,768 |
| 01/20/2026 | DDS | 8,567 | Direct | COM | $52.10 | $446,340.70 | 194,201 |
| 10/17/2025 | DDS | 50,895 | Direct | COM | $67.91 | $3,456,279.45 | 254,201 |
| 10/14/2025 | DDS | 4,242 | Direct | COM | $66.60 | $282,517.20 | 205,096 |
| 08/18/2025 | DDS | 13,081 | Direct | COM | $58.15 | $760,660.15 | 207,004 |
| 03/21/2025 | DDS | 10,031 | Direct | COM | $41.23 | $413,578.13 | 195,085 |
| 03/12/2025 | DDS | 4,462 | Direct | COM | $43.32 | $193,293.84 | 185,428 |
| 03/11/2025 | DDS | 9,973 | Direct | COM | $42.42 | $423,054.66 | 180,890 |
| 02/19/2025 | DDS | 18,360 | Direct | COM | $55.21 | $1,013,563.80 | 171,613 |
| 02/19/2025 | DDS | 6,928 | Direct | COM | $52.80 | $365,798.40 | 189,973 |
| 02/18/2025 | DDS | 11,640 | Direct | COM | $55.05 | $640,782.00 | 196,901 |
| 12/02/2024 | DDS | 15,000 | Direct | COM | $55.10 | $826,564.50 | 181,540 |
| 11/11/2024 | DDS | 23,121 | Direct | COM | $55.43 | $1,281,597.03 | 203,419 |
| 11/11/2024 | DDS | 6,879 | Direct | COM | $56.27 | $387,081.33 | 196,540 |
| 10/14/2024 | DDS | 4,293 | Direct | COM | $46.28 | $198,680.04 | 226,540 |
| 04/15/2024 | DDS | 1,204 | Direct | COM | $60.40 | $72,721.96 | 208,122 |
| 04/15/2024 | DDS | 18,378 | Direct | COM | $59.88 | $1,100,509.56 | 209,326 |
| 03/15/2024 | DDS | 10,613 | Direct | COM | $71.97 | $763,810.18 | 217,509 |
| 03/15/2024 | DDS | 9,387 | Direct | COM | $73.06 | $685,817.97 | 208,122 |
| 03/12/2024 | DDS | 4,583 | Direct | COM | $74.44 | $341,158.52 | 208,122 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research